
Yissum


Amphion builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK
Amphion has a significant shareholding in 7 Partner Companies developing proven technologi es targeting substantial commercial marketplaces, each in excess of $1 billion Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million
Amphion also has a specialized entity, DataTern, Inc , established to exploit IP opportunities within the Company's Partner Companies
2 images — click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Amphion Innovations.
Similar listings buyers compare against this one.

Yissum

Founders' Co-op

BioGenerator

Wellington Partners

Deepbridge Capital

Raba
Everything here links back to the same verified catalogue. Pick your next stop.